ArticleCluster computing2023
COVID-19 CT-images diagnosis and severity assessment using machine learning algorithm.
Article in Cluster computing, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Metaheuristic optimizers integrated with vision transformer model for severity detection and classification via multimodal COVID-19 images.Scientific reports · 2025Article
- A hybrid inception-dilated-ResNet architecture for deep learning-based prediction of COVID-19 severity.Scientific reports · 2025Article
- RETRACTED: LGD_Net: Capsule network with extreme learning machine for classification of lung diseases using CT scans.PloS one · 2025Article
- A tri-light warning system for hospitalized COVID-19 patients: Credibility-based risk stratification for future pandemic preparedness.European journal of radiology open · 2024Article
- A predictive model to explore risk factors for severe COVID-19.Scientific reports · 2024Article
- Deep Learning-Based Classification of Chest Diseases Using X-rays, CT Scans, and Cough Sound Images.Diagnostics (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a pandemic, the primary evaluation tool for coronavirus (COVID-19) still has serious flaws. To improve the existing situation, all facilities and tools available in this field should be used to combat the pandemic. Reverse transcription polymerase chain reaction is used to evaluate whether or not a person has this virus, but it cannot establish the severity of the illness. In this paper, we propose a simple, reliable, and automatic system to diagnose the severity of COVID-19 from the CT scans into three stages: mild, moderate, and severe, based on the simple segmentation method and three types of features extracted from the CT images, which are ratio of infection, statistical texture features (mean, standard deviation, skewness, and kurtosis), GLCM and GLRLM texture features. Four machine learning techniques (decision trees (DT), K-nearest neighbors (KNN), support vector machines (SVM), and Naïve Bayes) are used to classify scans. 1801 scans are divided into four stages based on the CT findings in the scans and the description file found with the datasets. Our proposed model divides into four steps: preprocessing, feature extraction, classification, and performance evaluation. Four machine learning algorithms are used in the classification step: SVM, KNN, DT, and Naive Bayes. By SVM method, the proposed model achieves 99.12%, 98.24%, 98.73%, and 99.9% accuracy for COVID-19 infection segmentation at the normal, mild, moderate, and severe stages, respectively. The area under the curve of the model is 0.99. Finally, our proposed model achieves better performance than state-of-art models. This will help the doctors know the stage of the infection and thus shorten the time and give the appropriate dose of treatment for this stage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.